In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

IPO nets $79mm for Amyris

Executive Summary

Amyris Biotechnologies Inc. (synthetic biology for drug and chemical production) has netted $79mm through its initial public offering of 5.3mm common shares priced at $16.
Deal Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
    • Nutraceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register